Canine vaccine recipients recognize an immunodominant region of the rabies virus glycoprotein

References

1. Anilionis A., Wunner W. H., Curtis P. J. 1981; Structure of the glycoprotein gene in rabies virus. Nature 294:275–278
   [Google Scholar]
2. Badrane H., Bahloul C., Perrin P., Tordo N. 2001; Evidence for two lyssavirus phylogroups with distinct pathogenicity and immunogenicity. Journal of Virology 75:3268–3276
   [Google Scholar]
3. Bunschoten H., Gore M., Claassen I. J. T. M., Uytdehaag F. G. C. M., Dietzschold B., Wunner W. H., Osterhaus A. D. M. E. 1989; Characterisation of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Journal of General Virology 70:291–298
   [Google Scholar]
4. Champion J. M., Kean R. B., Rupprecht C. E., Notkins A. L., Koprowski H., Dietzschold B., Hooper D. C. 2000; The development of monoclonal human rabies-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. Journal of Immunological Methods 231:81–90
   [Google Scholar]
5. Cliquet F., Aubert M., Sagne L. 1998; Development of a fluorescent antibody virus neutralisation test (FAVN) for the quantification of rabies-neutralizing antibody. Journal of Immunological Methods 212:79–87
   [Google Scholar]
6. Coll J. M. 1995; The glycoprotein G of rhabdoviruses. Archives of Virology 140:827–851
   [Google Scholar]
7. Coulon P., Derbin C., Kucera P., Lafay F., Prehaud C., Flamand A. 1989; Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. Journal of Virology 63:3550–3554
   [Google Scholar]
8. Coulon P., Lafay F., Flamand A. 1993; Rabies virus antigenicity: an overview. Onderstepoort Journal of Veterinary Virology 60:271–275
   [Google Scholar]
9. Dietzschold B., Wiktor T. J., Macfarlan R., Varrichio A. 1982; Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments. Journal of Virology 44:595–602
   [Google Scholar]
10. Dietzschold B., Wunner W. H., Tadeusz J. W., Lopes D., Lafon M., Smith C. L., Koprowski H. 1983; Characterization of an antigenic determinant of the rabies glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences, USA 80:70–74
    [Google Scholar]
11. Dietzschold B., Gore M., Marchadier D., Niu H. S., Bunschoten H. M., Otvos L. Jr, Wunner W. H., Ertl H. C. J., Osterhaus A. D. M. E., Koprowski H. 1990; Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Journal of Virology 64:3804–3809
    [Google Scholar]
12. Fooks T., McElhinney L. M., Brookes S. M., Johnson N., Keene V., Parsons G., Soldan A. 2002; Rabies antibody testing and the UK Pet Travel Scheme. Veterinary Record 150:428–430
    [Google Scholar]
13. Gaudin Y., Ruigrok R. W. H., Tuffereau C., Knossow M., Flamand A. 1992; Rabies virus glycoprotein is a trimer. Virology 184:441–444
    [Google Scholar]
14. Heaton P. R., Johnstone P., McElhinney L. M., Cowley R., O′Sullivan E., Whitby J. E. 1997; Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. Journal of Clinical Microbiology 35:2762–2766
    [Google Scholar]
15. Hemachuda T., Phuapradit P. 1997; Rabies. Current Opinion in Neurobiology 10:260–267
    [Google Scholar]
16. Hooper D. C., Morimoto K., Bette M., Weihem E., Koprowski H., Dietzschold B. 1998; Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. Journal of Virology 72:3711–3719
    [Google Scholar]
17. Lafay F., Benmansour A., Chebli K., Flamand A. 1996; Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. Journal of General Virology 77:339–346
    [Google Scholar]
18. Luo T. R., Minamoto N., Ito H., Goto H., Hiraga S., Ito N., Sugiyama M., Kinjo T. 1997; A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Research 51:35–41
    [Google Scholar]
19. Ni Y., Tominaga Y., Honda Y., Morimoto K., Sakamoto S., Kawai A. 1995; Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody Rg719. Microbiology and Immunology 39:693–702
    [Google Scholar]
20. Prehaud C., Coulon P., Lafay F., Thiers C., Flamand A. 1988; Antigenic site II of rabies virus glycoprotein: structure and role in viral virulence. Journal of Virology 62:1–7
    [Google Scholar]
21. Seif I., Coulon P., Rollin P. E., Flamand A. 1985; Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. Journal of Virology 53:926–934
    [Google Scholar]
22. Van der Heijden R. W. J., Langedijk J. P., Groen J., UytdeHaag F. G., Meloen R. H., Osterhaus A. D. 1993; Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. Journal of General Virology 74:1539–1545
    [Google Scholar]
23. Walker P. J., Kongsuwan K. 1999; Deduced structural model for animal rhabdovirus glycoproteins. Journal of General Virology 80:1211–1220
    [Google Scholar]